FrancophonIA/ELRC3.0 huggingface dataset:
English: Actraphane is a suspension for injection that contains the active substance human insulin.
Danish: Actraphane er en injektionsvæske, suspension, som indeholder det aktive stof human insulin.
English: Why has Actraphane been approved?
Danish: Hvorfor blev Actraphane godkendt?
English: Actraphane contains both fast-acting (soluble) and long-acting (isophane) insulin:
Danish: Actraphane indeholder både hurtigt virkende (opløseligt) insulin og langtidsvirkende (isofan) insulin:
English: Actraphane is a replacement insulin which is very similar to the insulin made by the pancreas.
Danish: Actraphane er et erstatningsinsulin, der næsten er identisk med det insulin, som produceres af bugspytkirtlen.
English: This gives Actraphane a longer duration of action.
Danish: Det giver Actraphane en længerevarende virkning.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Actraphane, including the appropriate precautions to be followed by healthcare professionals and patients.
Danish: Actraphane, herunder passende forholdsregler, som patienter og sundhedspersonale skal følge.
English: What benefit has Actraphane shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved Actraphane?
English: What is Actraphane?
Danish: Hvad er Actraphane?
English: What is Actraphane used for?
Danish: Hvad anvendes Actraphane til?
English: How has Actraphane been studied?
Danish: Hvordan blev Actraphane undersøgt?
English: How is Actraphane used?
Danish: Hvordan anvendes Actraphane?
English: How does Actraphane work?
Danish: Hvordan virker Actraphane?
English: The full EPAR and risk management plan summary for DuoResp Spiromax can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR og resuméet af risikostyringsplanen for DuoResp Spiromax findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The European Commission granted a marketing authorisation valid throughout the European Union for DuoResp Spiromax on 28 April 2014.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for DuoResp Spiromax den 28. april 2014.
English: The company initially also applied for a lower strength of DuoResp Spiromax, however bioequivalence to the reference product was not demonstrated and the application for this strength was withdrawn.
Danish: Virksomheden ansøgte oprindeligt om en lavere styrke af DuoResp Spiromax, men der blev ikke påvist bioækvivalens med referenceproduktet, og ansøgningen for denne styrke blev trukket tilbage.
English: This is a summary of the European public assessment report (EPAR) for DuoResp Spiromax.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for DuoResp Spiromax.
English: A risk management plan has been developed to ensure that DuoResp Spiromax is used as safely as possible.
Danish: Der er udarbejdet en risikostyringsplan for at sikre, at DuoResp Spiromax anvendes så sikkert som muligt.
English: The two active substances in DuoResp Spiromax are well known and are present in several medicines used to treat asthma and COPD, either alone or in combination with other medicines.
Danish: De to aktive stoffer i DuoResp Spiromax er velkendte og findes i flere lægemidler, der anvendes til behandling af astma og KOL, enten alene eller i kombination med andre lægemidler.
English: DuoResp Spiromax is also used to relieve the symptoms of severe chronic obstructive pulmonary disease (COPD) in adults who have had exacerbations (flare-ups) of the disease in the past despite regular treatment.
Danish: DuoResp Spiromax anvendes desuden til lindring af symptomerne på svær kronisk obstruktiv lungesygdom (KOL) hos voksne, når de tidligere har haft anfald med forværring af sygdommen trods regelmæssig behandling.
English: This means that it is similar to a ‘reference medicine' containing the same active substances, but DuoResp Spiromax is given using a different inhaler.
Danish: Det betyder, at det svarer til et “referencelægemiddel”, der indeholder samme aktive stoffer, men til DuoResp Spiromax anvendes en anden inhalator.
English: DuoResp Spiromax budesonide / formoterol
Danish: DuoResp Spiromax budesonid/formoterol
English: The higher strength, DuoResp Spiromax 320/9 microgram (320 micrograms of budesonide and 9 micrograms of formoterol), can only be used for the regular treatment of asthma and for the treatment of COPD.
Danish: Den større styrke DuoResp Spiromax 320/9 µg (320 µg budesonid og 9 µg formoterol) kan kun anvendes til regelmæssig behandling af astma og til behandling af KOL.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for DuoResp Spiromax, including the appropriate precautions to be followed by healthcare professionals and patients.
Danish: På baggrund af denne er der anført sikkerhedsoplysninger i produktresuméet og indlægssedlen for DuoResp Spiromax, herunder passende forholdsregler, som patienter og sundhedspersonale skal følge.
English: As asthma reliever therapy, patients can take 1 or 2 additional inhalations of DuoResp Spiromax 160/4.5 microgram only to relieve their symptoms.
Danish: Til lindring af astma må patienterne kun tage en eller to ekstra inhalationer af DuoResp Spiromax 160/4,5 µg for at lindre symptomerne.
English: DuoResp Spiromax is a medicine that contains the active substances budesonide and formoterol.
Danish: DuoResp Spiromax er et lægemiddel, der indeholder de to aktive stoffer budesonid og formoterol.
English: What measures are being taken to ensure the safe and effective use of DuoResp Spiromax?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af DuoResp Spiromax?
English: Other information about DuoResp Spiromax
Danish: Andre oplysninger om DuoResp Spiromax
English: What are the benefits and risks of DuoResp Spiromax?
Danish: Hvilke fordele og risici er der forbundet med DuoResp Spiromax?
English: For more information about treatment with DuoResp Spiromax, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med DuoResp Spiromax, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: DuoResp Spiromax is a ‘hybrid medicine'.
Danish: DuoResp Spiromax er et “hybridt lægemiddel”.
English: What is DuoResp Spiromax and what is it used for?
Danish: Hvad er DuoResp Spiromax, og hvad anvendes det til?
English: Because DuoResp Spiromax is a hybrid medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Danish: Da DuoResp Spiromax er et hybridt lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
English: The Committee recommended that DuoResp Spiromax be given marketing authorisation.
Danish: Udvalget anbefalede udstedelse af markedsføringstilladelse for DuoResp Spiromax.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that DuoResp Spiromax 160/4.5 microgram and 320/9 microgram have been shown to have comparable quality and to be bioequivalent to the corresponding strengths of Symbicort Turbohaler.
Danish: Udvalget for Lægemidler til Mennesker (CHMP) konkluderede, at DuoResp Spiromax, 160/4,5 µg og 320/9 µg, er påvist at have en kvalitet svarende til Symbicort Turbohaler og at være bioækvivalent med dette.
English: The reference medicine for DuoResp Spiromax is Symbicort Turbohaler.
Danish: Referencelægemidlet for DuoResp Spiromax er Symbicort Turbohaler.
English: It is not intended to provide practical advice on how to use DuoResp Spiromax.
Danish: Det er ikke en praktisk vejledning i, hvordan DuoResp Spiromax bør anvendes.
English: Studies in patients have been limited to tests to determine that DuoResp Spiromax is bioequivalent to the reference medicine, Symbicort Turbohaler.
Danish: Patientundersøgelserne har været begrænset til at påvise, at DuoResp Spiromax er bioækvivalent med referencelægemidlet Symbicort Turbohaler.
English: For practical information about using DuoResp Spiromax, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning i anvendelsen af DuoResp Spiromax, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: Why is DuoResp Spiromax approved?
Danish: Hvorfor er DuoResp Spiromax blevet godkendt?
English: How has DuoResp Spiromax been studied?
Danish: Hvordan blev DuoResp Spiromax undersøgt?
English: How is DuoResp Spiromax used?
Danish: Hvordan anvendes DuoResp Spiromax?
English: How does DuoResp Spiromax work?
Danish: Hvordan virker DuoResp Spiromax?
English: (Invented) name Strength Pharmaceutical Form Route of Administration
Danish: Særnavn Styrke
English: 169 29 Solna SWEDEN
Danish: 169 29 Solna SVERIGE
English: Arquiparque - Miraflores 1495-131 Algés PORTUGAL
Danish: Arquiparque - Miraflores 1495-131 Algés
English: Intravenous Use and Intramuscular use (Only one MA for 250 mg strength)
Danish: Intravenøs anvendelse og Intramuskulær anvendelse (Kun en MA for styrken 250 mg)
English: Kifissias 266, 152 32 Halandri, Athens GREECE
Danish: 152 32 Halandri, Athens GRÆKENLAND
English: GlaxoSmithKline Export Ltd. 980 Great West Road Brentford, Middlesex, TW8 9GS
Danish: GlaxoSmithKline Export Ltd. 980 Great West Road Brentford, Middlesex, TW8 9GS STORBRITANNIEN
English: GSK d.o.o., Ljubljana Cvetkova ulica 29 SI-1000 Ljubljana SLOVENIA
Danish: GSK d.o.o., Ljubljana Cvetkova ulica 29SI-1000 Ljubljana SLOVENIEN
English: Middlex UB6 0NN UNITED KINGDOM
Danish: Middlex UB6 0NN STORBRITANNIEN
English: GlaxoSmithKline 100, route de Versailles78163 Marly-le-Roi Cedex FRANCE
Danish: Laboratoire GlaxoSmithKline 100, route de Versailles - 78163 Marly-le-Roi Cedex FRANKRIG
English: Middlesex UB6 0HE UNITED KINGDOM
Danish: Middlesex UB6 0HE STORBRITANNIEN
English: 750mg +1 x 6ml solvent
Danish: 750mg +1 x 6 ml solvens
English: 250mg + 1 x 2ml solvent
Danish: 250 mg + 1 x 2 ml solvens
English: SLOVENIA
Danish: Slovenien
English: Glaxo Smith Kline B.V. Huis ter Heideweg 62 3705 LZ ZEIST NETHERLANDS
Danish: Huis ter Heideweg 62 3705 LZ ZEIST HOLLAND
English: 250mg 2ml (intravenous) 250mg/1ml (intramuscular)
Danish: 250mg/2ml (intravenøs) 250mg/1ml (intramuskulær)
English: 250mg/1ml or 250mg/2-5ml
Danish: 250mg/1ml eller 250mg/ 2-5ml
English: GlaxoSmithKline Pharma GmbH, Albert SchweitzerGasse 6,
Danish: GlaxoSmithKline Pharma GmbH, Albert Schweitzer-Gasse 6, A-1140 Wien
English: Injection : 1.5g/15ml Infusion : 1.5g/15ml + 50ml or 100ml
Danish: Injektion: 1,5g /15ml Infusion: 1,5g/15 ml + 50ml eller 100ml
English: 750mg/6ml (intravenous) 750mg/3ml (intramuscular)
Danish: 750mg/6ml (intravenøs) 750mg/3ml (intramuskulær)
English: GSK d.o.o., Ljubljana Cvetkova ulica 29SI-1000 Ljubljana
Danish: GSK d.o.o., Ljubljana Cvetkova ulica 29
English: Curocef 250 mgTrockenstechamupll en
Danish: Curocef 250 mgTrockenstechamupllen 250mg
English: Curocef 1500 mgTrockenstechampull en
Danish: Curocef 1500 mgTrockenstechampullen 1,5g
English: Powder and solvent for suspension for Injection
Danish: Pulver og solvens til injektionsvæske, suspension
English: 750mg/3ml or 750 mg/6 - 10 ml
Danish: 750mg/3ml eller 750mg/ 6-10ml
English: 750mg Powder for Solution for Infusion
Danish: 750mg Powder for suspension for Injection
English: Curocef 750 mgTrockenstechampull en
Danish: Curocef 750 mgTrockenstechampullen 750mg
English: 250mg/VIAL
Danish: 250mg/HÆTTEGLAS
English: Glaxo Group Ltd., Greenford, Middlesex UB6 0NN
Danish: Glaxo Group Ltd., Greenford, Middlesex UB6 0NN STORBRITANNIEN
English: Glaxo Wellcome House Berkeley Avenue Greenford
Danish: Glaxo Operations UK Limited Glaxo Wellcome House Berkeley Avenue Greenford
English: HUNGARY
Danish: UNGARN
English: ICELAND
Danish: Island
English: Nykaer 68, 2605 Broendby DENMARK
Danish: GlaxoSmithKline Pharma A/S Nykær 68, 2605 Brøndby DANMARK
English: GlaxoSmithKline Pharma A/S
Danish: GlaxoSmithKline s.a. / n.v.
English: Intramuscular Use, Intravenous Use
Danish: Intramuskulær anvendelse, Intravenøs anvendelse
English: 1.5g/VIAL
Danish: 1,5g/HÆTTEGLAS
English: Intravenous or Intramuscular Use
Danish: Intravenøs eller intramuskulær anvendelse
English: Powder for suspension for Injection
Danish: Pulver til injektionsvæske, suspension
English: Glaxo Group LtdGlaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN UNITED KINGDOM
Danish: Glaxo Group LtdGlaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN STORBRITANNIEN
English: Intravenous use, intramuscular use
Danish: Intravenøs anvendelse, intramuskulær anvendelse
English: Intravenous Use/ Intramuscular Use
Danish: Intravenøs anvendelse/ Intramuskulær anvendelse
English: Intramuscular Use/ Intravenous Use
Danish: Intramuskulær anvendelse / Intravenøs anvendelse
English: 750mg/VIAL
Danish: 750mg/HÆTTEGLAS
English: Powder for suspension for injection or solution for injection and infusion
Danish: Pulver til injektionsvæske, suspension eller injektions/infusionsvæske, opløsning
English: Powder for injection or solution for infusion
Danish: Pulver til injektionsvæske eller infusionsvæske, opløsning
English: Powder for solution for Injection
Danish: Pulver til infusionsvæske
English: Intravenous Use and Intramuscular use
Danish: Intravenøs anvendelse og intramuskulær anvendelse
English: GlaxoSmithKline s.a. / n.v. Rue du Tilleul 13
Danish: Rue du Tilleul 13
English: Powder for solution/ suspension for injection/infusion
Danish: Pulver til injektions/infusionsvæske, opløsning/suspension
English: 250mg Powder for Injection Intramuscular Use
Danish: 250mg Injektionsvæske, opløsning
English: Powder for suspension for Infusion
Danish: Pulver til infusionsvæske, suspension
English: Powder for Solution /Suspension for Injection
Danish: Pulver til injektionsvæske, opløsning/suspension
English: Powder for Solution for injection or Infusion
Danish: Pulver til injektions-/infusionsv æske
English: Powder for solution or suspension for injection
Danish: Pulver injektionsvæske, opløsning eller suspension
English: 750mg Powder for Injection Intramuscular Use
Danish: 750mg Injektionsvæske, opløsning
English: A-1140 Wien AUSTRIA
Danish: SI-1000 Ljubljana SLOVENIEN
English: It will not be given to you again.
Danish: Den vil ikke blive givet til dig igen.
English: This usually takes less than 1 hour.
Danish: Dette tager normalt mindre end 1 time.
English: 9 months.
Danish: 9 måneder.
English: * Frequency is based on laboratory values.
Danish: * Frekvensen er baseret på laboratorieværdier.
English: • You have an infection.
Danish: • Du har en infektion.
English: These other medicines may include:
Danish: Disse andre lægemidler kan omfatte:
English: Name:
Danish: Navn:
English: No such risks were identified based on these studies.
Danish: Der blev ikke identificeret sådanne risici på baggrund af disse studier.
English: June 2022
Danish: Juni 2022
English: Date of birth: {DD MMM YYYY} SEC:
Danish: Fødselsdato: {DD MMM ÅÅÅÅ} SEC:
English: This can take 3 to 6 hours and may need to be repeated.
Danish: Dette kan tage 3 til 6 timer, og det kan være nødvendigt at gentage proceduren.
English: Kymriah should only be given if the result shows you are not pregnant.
Danish: Kymriah bør kun gives, hvis resultatet viser, at du ikke er gravid.
English: In addition the applicant should submit the final CSR including 5 years of follow-up.
Danish: Derudover skal ansøgeren indsende den endelige CSR inklusive 5 års opfølgning.
English: TLS, which may be severe, has occasionally been observed.
Danish: TLS, som kan være alvorligt, er lejlighedsvist blevet observeret.
English: Race/ethnicity
Danish: Race/etnicitet
English: Key elements:
Danish: Nøgleelementer:
English: Other side effects are listed below.
Danish: Andre bivirkninger er listet nedenunder.
English: • There may be an effect on the results of some types of HIV test - ask your doctor about this.
Danish: • Der kan være en påvirkning af resultaterne af nogle typer HIV-tests - tal med lægen om dette.
English: • You had a vaccination in the previous 6 weeks or are planning to have one in the next few months.
Danish: • Du har fået en vaccination inden for de sidste 6 uger eller planlægger at få en inden for nogle måneder.
English: Do not drive, use machines, or take part in activities that need you to be alert for.
Danish: Du må ikke føre motorkøretøj, betjene maskiner eller deltage i aktiviteter, der kræver, at du er opmærksom.
English: Patients should be monitored for neurological events.
Danish: Patienterne skal monitoreres for neurologiske hændelser.
English: You may be given medicines to help prevent the condition.
Danish: Du vil få lægemidler, der kan hjælpe med at forebygge tilstanden.
English: They should be monitored life-long for secondary malignancies.
Danish: De bør monitoreres livslangt for sekundære maligniteter.
English: T½ (day)
Danish: T½ (dag)
English: - The information in this leaflet is for you or your child - but in the leaflet it will just say “you”.
Danish: - Informationen i denne indlægsseddel er til dig eller dit barn - men i indlægssedlen vil der blot stå “du”.
English: Bag x of y
Danish: Pose x af y
English: • You have had a stem cell transplant in the last 4 months.
Danish: • Du har fået en stamcelletransplantation i løbet af de sidste 4 måneder.
English: ORR included CR and CRi.
Danish: ORR omfattede CR og CRi.
English: These patient are likely to be more vulnerable to the consequences of the adverse reactions described below and require special attention.
Danish: Disse patienter er sandsynligvis mere sårbare overfor konsekvenserne af de bivirkninger, der er beskrevet nedenfor, og kræver særlig opmærksomhed.
English: No alternative adequate animal models are available.
Danish: Der findes ingen andre fyldestgørende dyremodeller.
English: • Reduced levels of one or more blood cell types
Danish: • Lavt niveau af en eller flere typer blodceller
English: • You notice the symptoms of your cancer are getting worse.
Danish: • Du bemærker, at symptomerne på din cancer bliver værre.
English: Manufacture and release of Kymriah usually takes about 3-4 weeks.
Danish: Fremstilling og frigivelse af Kymriah tager normalt omkring 3-4 uger.
English: Reasons to delay treatment
Danish: Årsager til udsættelse af behandlingen
English: Response at month 3
Danish: Respons ved måned 3
English: - Active uncontrolled infection.
Danish: - Aktiv, ukontrolleret infektion.
English: Response at month 6
Danish: Respons ved måned 6
English: Summary statistics
Danish: Opsummerende statistik
English: • Very severe inflammation around the body (due to syndrome of immune activation)
Danish: • Meget svær inflammation rundt om i kroppen (pga. af syndrom med aktivering af immunforsvaret)
English: Your doctor will check if you have signs or symptoms of graft-versus-host disease.
Danish: Din læge vil kontrollere, om du har tegn eller symptomer på graft-versus-host-sygdom.
English: In particular, you must not be given certain vaccines called live vaccines:
Danish: Det er især vigtigt, at du ikke får en bestemt type vaccine, kaldet en levende vaccine:
English: The cellular composition and the final cell number varies between individual patient batches.
Danish: Den cellulære sammensætning og det endelige celleantal varierer mellem de enkelte patientbatches.
English: • Look for signs of graft-versus-host disease that can happen after a transplant.
Danish: • Se efter tegn på graft-versus-host-sygdom, som kan opstå efter en transplantation.
English: • Red or purple spots under the skin
Danish: • Røde eller lilla pletter under huden
English: The product should be administered immediately after thawing.
Danish: Produktet bør administreres umiddelbart efter optøning.
English: • after treatment while the immune system is recovering.
Danish: • efter behandlingen, mens immunforsvaret bliver genoprettet.
English: UNIQUE IDENTIFIER - 2D BARCODE Not applicable
Danish: ENTYDIG IDENTIFIKATOR - 2D-STREGKODE Ikke relevant
English: If you miss an appointment, call your doctor or the hospital as soon as possible to reschedule.
Danish: Hvis du glemmer en aftale, skal du ringe til din læge eller hospitalet hurtigst mulig for at få en ny aftale.
English: These symptoms almost always occur within the first 10 days after infusion.
Danish: Disse symptomer forekommer næsten altid inden for de første 10 dage efter infusion.
English: Therefore the risk/benefit of Kymriah has not been established in these populations.
Danish: Derfor er risk/benefit forholdet for Kymriah ikke etableret i denne population.
English: Therefore, leukapheresis material from these patients will not be accepted for Kymriah manufacturing.
Danish: Derfor vil leukaferesemateriale fra disse patienter ikke blive accepteret til fremstilling af Kymriah.
English: • Blue lips, hands and feet
Danish: • Blålige læber, hænder og fødder
English: Availability of tocilizumab and site qualification
Danish: Tilgængeligheden af tocilizumab og stedets kvalifikation
English: Prolonged neutropenia has been associated with increased risk of infection.
Danish: Neutropeni af længere varighed er blevet forbundet med øget risiko for infektion.
English: This is because the effects of Kymriah in pregnant or breast-feeding women are not known, and it may harm your unborn baby or your newborn/infant.
Danish: Grunden er, at Kymriahs virkning hos gravide eller ammende kvinder ikke kendes, og det kan måske skade dit ufødte barn eller dit nyfødte barn/spædbarn.
English: Approximately 30% of patients discontinued the study prior to Kymriah administration.
Danish: Omkring 30 % af patienterne udgik fra studiet før administration af Kymriah.
English: Read all of this leaflet carefully before you (or your child) are given this medicine because it contains important information.
Danish: Læs denne indlægsseddel grundigt, inden du (eller dit barn) får behandling med dette lægemiddel, da den indeholder vigtige oplysninger.
English: It is unknown whether Kymriah cells are excreted in human milk.
Danish: Det er ukendt, om Kymriah celler udskilles i human mælk.
English: In all indications, appropriate prophylactic and therapeutic treatment for infections should be provided, and complete resolution of any existing infections should be ensured.
Danish: For all indikationer skal der gives passende profylaktisk og terapeutisk behandling af infektioner, og komplet resolution af enhver eksisterende infektion skal sikres.
English: Disease status (%) Primary refractory1
Danish: Sygdomsstatus (%) Primær refraktær1
English: Repeat tocilizumab as needed at a minimum interval of 8 hours if there is no clinical improvement.
Danish: Gentag tocilizumab efter behov med et minimuminterval på 8 timer, hvis der ikke er klinisk forbedring.
English: Some of your white blood cells are separated from your blood and the rest of your blood is returned to your vein.
Danish: Nogle af dine hvide blodlegemer udskilles fra dit blod, og resten af dit blod returneres til din vene.
English: This is to help prevent infusion reactions and fever.
Danish: Dette er for at forebygge infusionsreaktioner og feber.
English: • Take your temperature twice a day for 3-4 weeks after treatment with Kymriah.
Danish: • Målt din temperatur to gange daglig i 3-4 uger efter behandling med Kymriah.
English: Your doctor will recommend that you return to the hospital daily for at least 10 days and will consider whether you need to stay at the hospital as an in-patient for the first 10 days after infusion.
Danish: Din læge vil anbefale, at du kommer ind på hospitalet dagligt i mindst 10 dage og vil vurdere, om du har behov for at blive indlagt på hospitalet i de første 10 dage efter infusionen.
English: Your doctor will regularly check your blood counts as the number of blood cells and other blood components may decrease.
Danish: Din læge vil regelmæssigt måle dine blodtal, da antallet af blodceller og andre blodkomponenter kan falde.